{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:38:53Z","timestamp":1791833933821,"version":"4.3.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K16223, 19K08729, 22K08311, 17K09706, 19K08728, 22K08357"],"award-info":[{"award-number":["22K16223, 19K08729, 22K08311, 17K09706, 19K08728, 22K08357"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Strategic Grants from the Center for Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences","award":["09021407"],"award-info":[{"award-number":["09021407"]}]},{"name":"Kumamoto University Hospital Young Researcher Activation Project","award":["R4-6, R5-3"],"award-info":[{"award-number":["R4-6, R5-3"]}]},{"name":"Platform Project for Supporting Drug Discovery and Life Science Research","award":["JP23ama121053"],"award-info":[{"award-number":["JP23ama121053"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98894-0","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:30:55Z","timestamp":1745544655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Alvespimycin is identified as a novel therapeutic agent for diabetic kidney disease by chemical screening targeting extracellular vesicles"],"prefix":"10.1038","volume":"15","author":[{"given":"Daisuke","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuro","family":"Umemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruhiko","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Nishiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Date","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kakizoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotatsu","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Mukoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashige","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"98894_CR1","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Thery, C. Communication by extracellular vesicles: Where we are and where we need to go. Cell 164, 1226\u20131232 (2016).","journal-title":"Cell"},{"key":"98894_CR2","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","volume":"33","author":"R Isaac","year":"2021","unstructured":"Isaac, R., Reis, F. C. G., Ying, W. & Olefsky, J. M. Exosomes as mediators of intercellular crosstalk in metabolism. Cell Metab. 33, 1744\u20131762 (2021).","journal-title":"Cell Metab."},{"key":"98894_CR3","doi-asserted-by":"publisher","first-page":"F844","DOI":"10.1152\/ajprenal.00429.2016","volume":"311","author":"W Zhang","year":"2016","unstructured":"Zhang, W. et al. Extracellular vesicles in diagnosis and therapy of kidney diseases. Am. J. Physiol. Renal. Physiol. 311, F844\u2013F851 (2016).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"98894_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","volume":"75","author":"NP Hessvik","year":"2018","unstructured":"Hessvik, N. P. & Llorente, A. Current knowledge on exosome biogenesis and release. Cell. Mol. Life Sci. 75, 193\u2013208 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"98894_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.33594\/000000207","volume":"54","author":"T Medeiros","year":"2020","unstructured":"Medeiros, T., Myette, R. L., Almeida, J. R., Silva, A. A. & Burger, D. Extracellular vesicles: Cell-derived biomarkers of glomerular and tubular injury. Cell Physiol. Biochem. 54, 88\u2013109 (2020).","journal-title":"Cell Physiol. Biochem."},{"key":"98894_CR6","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","volume":"55","author":"T Kuwabara","year":"2012","unstructured":"Kuwabara, T. et al. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 55, 2256\u20132266 (2012).","journal-title":"Diabetologia"},{"key":"98894_CR7","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1038\/s41598-020-59970-9","volume":"10","author":"Y Hata","year":"2020","unstructured":"Hata, Y. et al. Ablation of myeloid cell MRP8 ameliorates nephrotoxic serum-induced glomerulonephritis by affecting macrophage characterization through intraglomerular crosstalk. Sci Rep. 10, 3056 (2020).","journal-title":"Sci Rep."},{"key":"98894_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1242\/bio.015990","volume":"5","author":"XM Wu","year":"2016","unstructured":"Wu, X. M., Gao, Y. B., Cui, F. Q. & Zhang, N. Exosomes from high glucose-treated glomerular endothelial cells activate mesangial cells to promote renal fibrosis. Biol Open 5, 484\u2013491 (2016).","journal-title":"Biol Open"},{"key":"98894_CR9","doi-asserted-by":"publisher","first-page":"121991","DOI":"10.1016\/j.lfs.2023.121991","volume":"330","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Macrophage-derived exosomes promote activation of NLRP3 inflammasome and autophagy deficiency of mesangial cells in diabetic nephropathy. Life Sci. 330, 121991 (2023).","journal-title":"Life Sci."},{"key":"98894_CR10","doi-asserted-by":"publisher","first-page":"e34653","DOI":"10.1371\/journal.pone.0034653","volume":"7","author":"A Waldenstrom","year":"2012","unstructured":"Waldenstrom, A., Genneback, N., Hellman, U. & Ronquist, G. Cardiomyocyte microvesicles contain DNA\/RNA and convey biological messages to target cells. PLoS ONE 7, e34653 (2012).","journal-title":"PLoS ONE"},{"key":"98894_CR11","doi-asserted-by":"publisher","first-page":"4084","DOI":"10.1038\/s41467-023-39404-6","volume":"14","author":"Y Minami","year":"2023","unstructured":"Minami, Y. et al. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion. Nat. Commun. 14, 4084 (2023).","journal-title":"Nat. Commun."},{"key":"98894_CR12","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1021\/acs.jmedchem.2c02059","volume":"66","author":"Y Nishigaya","year":"2023","unstructured":"Nishigaya, Y. et al. Discovery of novel substrate-competitive lysine methyltransferase G9a inhibitors as anticancer agents. J.Med. Chem. 66, 4059\u20134085 (2023).","journal-title":"J.Med. Chem."},{"key":"98894_CR13","doi-asserted-by":"publisher","first-page":"33935","DOI":"10.1038\/srep33935","volume":"6","author":"W Nakai","year":"2016","unstructured":"Nakai, W. et al. A novel affinity-based method for the isolation of highly purified extracellular vesicles. Sci. Rep. 6, 33935 (2016).","journal-title":"Sci. Rep."},{"key":"98894_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nature06307","volume":"450","author":"M Miyanishi","year":"2007","unstructured":"Miyanishi, M. et al. Identification of Tim4 as a phosphatidylserine receptor. Nature 450, 435\u2013439 (2007).","journal-title":"Nature"},{"key":"98894_CR15","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.annonc.2022.05.518","volume":"33","author":"Y Kurokawa","year":"2022","unstructured":"Kurokawa, Y. et al. Pimitespib in patients with advanced gastrointestinal stromal tumor (CHAPTER-GIST-301): A randomized, double-blind, placebo-controlled phase III trial. Ann. Oncol. 33, 959\u2013967 (2022).","journal-title":"Ann. Oncol."},{"key":"98894_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-019-0234-4","volume":"16","author":"SCW Tang","year":"2020","unstructured":"Tang, S. C. W. & Yiu, W. H. Innate immunity in diabetic kidney disease. Nat. Rev. Nephrol. 16, 206\u2013222 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"98894_CR17","doi-asserted-by":"publisher","first-page":"1015142","DOI":"10.3389\/fimmu.2022.1015142","volume":"13","author":"HD Li","year":"2022","unstructured":"Li, H. D. et al. Roles and crosstalks of macrophages in diabetic nephropathy. Front. Immunol. 13, 1015142 (2022).","journal-title":"Front. Immunol."},{"key":"98894_CR18","doi-asserted-by":"publisher","first-page":"15577","DOI":"10.1096\/fj.202000078RR","volume":"34","author":"D Fujimoto","year":"2020","unstructured":"Fujimoto, D. et al. Suppressed ER-associated degradation by intraglomerular cross talk between mesangial cells and podocytes causes podocyte injury in diabetic kidney disease. FASEB J. 34, 15577\u201315590 (2020).","journal-title":"FASEB J."},{"key":"98894_CR19","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"98894_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1479-5876-10-134","volume":"10","author":"AM Marleau","year":"2012","unstructured":"Marleau, A. M., Chen, C. S., Joyce, J. A. & Tullis, R. H. Exosome removal as a therapeutic adjuvant in cancer. J. Transl. Med. 10, 134 (2012).","journal-title":"J. Transl. Med."},{"key":"98894_CR21","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/ijms18030538","volume":"18","author":"HR Mohammed","year":"2017","unstructured":"Mohammed, H. R. et al. Exosomes: From garbage bins to promising therapeutic targets. Int. J. Mol. Sci. 18, 538 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"98894_CR22","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s12943-020-01278-3","volume":"19","author":"Z Xu","year":"2020","unstructured":"Xu, Z., Zeng, S., Gong, Z. & Yan, Y. Exosome-based immunotherapy: A promising approach for cancer treatment. Mol. Cancer 19, 160 (2020).","journal-title":"Mol. Cancer"},{"key":"98894_CR23","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1681\/ASN.2015010074","volume":"27","author":"U Erdbrugger","year":"2016","unstructured":"Erdbrugger, U. & Le, T. H. extracellular vesicles in renal diseases: More than novel biomarkers?. J. Am. Soc. Nephrol. 27, 12\u201326 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"98894_CR24","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/ndt\/gfac235","volume":"38","author":"CF Rudolphi","year":"2023","unstructured":"Rudolphi, C. F., Blijdorp, C. J., van Willigenburg, H., Salih, M. & Hoorn, E. J. Urinary extracellular vesicles and tubular transport. Nephrol. Dial. Transpl. 38, 1583\u20131590 (2023).","journal-title":"Nephrol. Dial. Transpl."},{"key":"98894_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.kint.2020.10.041","volume":"99","author":"H Hamano","year":"2021","unstructured":"Hamano, H. et al. Diphenhydramine may be a preventive medicine against cisplatin-induced kidney toxicity. Kidney Int. 99, 885\u2013899 (2021).","journal-title":"Kidney Int."},{"key":"98894_CR26","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.kint.2023.02.010","volume":"103","author":"JX Zhou","year":"2023","unstructured":"Zhou, J. X. & Torres, V. E. Drug repurposing in autosomal dominant polycystic kidney disease. Kidney Int. 103, 859\u2013871 (2023).","journal-title":"Kidney Int."},{"key":"98894_CR27","doi-asserted-by":"publisher","first-page":"113431","DOI":"10.1016\/j.celrep.2023.113431","volume":"42","author":"SI Mae","year":"2023","unstructured":"Mae, S. I. et al. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD. Cell Rep. 42, 113431 (2023).","journal-title":"Cell Rep."},{"key":"98894_CR28","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1007\/s40265-022-01764-6","volume":"82","author":"SM Hoy","year":"2022","unstructured":"Hoy, S. M. Pimitespib: First approval. Drugs 82, 1413\u20131418 (2022).","journal-title":"Drugs"},{"key":"98894_CR29","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/cvr\/cvq046","volume":"86","author":"J Madrigal-Matute","year":"2010","unstructured":"Madrigal-Matute, J. et al. Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc. Res. 86, 330\u2013337 (2010).","journal-title":"Cardiovasc. Res."},{"key":"98894_CR30","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.2337\/db14-1926","volume":"64","author":"I Lazaro","year":"2015","unstructured":"Lazaro, I. et al. Targeting HSP90 ameliorates nephropathy and atherosclerosis through suppression of NF-kappaB and STAT signaling pathways in diabetic mice. Diabetes 64, 3600\u20133613 (2015).","journal-title":"Diabetes"},{"key":"98894_CR31","doi-asserted-by":"publisher","first-page":"e002579","DOI":"10.1136\/bmjdrc-2021-002579","volume":"10","author":"X Ding","year":"2022","unstructured":"Ding, X. et al. Extracellular Hsp90alpha, which participates in vascular inflammation, is a novel serum predictor of atherosclerosis in type 2 diabetes. BMJ Open Diabetes Res Care. 10, e002579 (2022).","journal-title":"BMJ Open Diabetes Res Care."},{"key":"98894_CR32","doi-asserted-by":"crossref","unstructured":"Lauwers, E. et al. Hsp90 mediates membrane deformation and exosome release. Mol. Cell. 71, 689\u2013702 e9 (2018).","DOI":"10.1016\/j.molcel.2018.07.016"},{"key":"98894_CR33","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/128_2012_356","volume":"328","author":"SE Jackson","year":"2013","unstructured":"Jackson, S. E. Hsp90: Structure and function. Top Curr. Chem 328, 155\u2013240 (2013).","journal-title":"Top Curr. Chem."},{"key":"98894_CR34","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/j.freeradbiomed.2010.03.001","volume":"48","author":"Y Samuni","year":"2010","unstructured":"Samuni, Y. et al. Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs. Free Radic. Biol. Med. 48, 1559\u20131563 (2010).","journal-title":"Free Radic. Biol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98894-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98894-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98894-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T01:30:58Z","timestamp":1745544658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98894-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98894"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98894-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4010567\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14436"}}